Tag Archives: adherence
By Guest Blogger | Published: April 8, 2013
by Grant Corbett Improving brand adherence rates requires pharma marketers to have access to two growing bodies of knowledge. These are: 1) carefully evaluated evidence for what can improve brand revenue, and 2) informed forecasts of trends.
By Guest Blogger | Published: March 12, 2013
by Grant Corbett Epigenetics is the study of changes in human gene expression, in particular from environmental factors. Pharma is also experiencing epigenetic change. Human genes are formed from DNA, which are instructions much like a blueprint. Similarly, the environment is changing pharmaceutical DNA and how brand marketing is instructed.
By Guest Blogger | Published: April 18, 2012
Chris Evans, West Pharmaceutical Services, and Ed Geiselhart, Insight Product Development, consider the importance of drug delivery systems in facilitating patient adherence. No two patients are alike, but drug-makers may not consider how different a single patient’s perspective can be when viewed over time. A patient’s progress through disease management is a journey, and perceptions change [...]
By Jennifer Ringler | Published: April 6, 2012
Medication adherence is an ongoing and serious problem; according to the Center for Health Transformation, the annual cost of patients not taking their medicines as prescribed is nearly $300 billion, with approximately 125,000 patients dying each year due to poor adherence—that’s 342 people every day. Improving adherence rates in the United States has been a [...]
By Jennifer Ringler | Published: February 7, 2011
Patient adherence is a chronic issue in healthcare, leading to poor disease management, higher hospitalization rates, and lost revenue for Big Pharma. But one often overlooked facet of the complicated chain of events from R&D to marketing to prescribing may hold the key. Patient adherence is not a new issue in the industry; still, the [...]